Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
1
TGA:1
Drug Approvals
IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion (391413)
- Product Name
- IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion
- Approval Date
- Jul 10, 2023
TGA
Clinical Trials
No trials found
News
No news found